Sensei Biotherapeutics Inc is a biotechnology business based in the US. Sensei Biotherapeutics shares (SNSE) are listed on the NASDAQ and all prices are listed in US Dollars. Sensei Biotherapeutics employs 30 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Sensei Biotherapeutics
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – SNSE – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Sensei Biotherapeutics stock price (NASDAQ: SNSE)Use our graph to track the performance of SNSE stocks over time.
Sensei Biotherapeutics shares at a glance
|Latest market close||$7.46|
|52-week range||$6.71 - $26.50|
|50-day moving average||$9.65|
|200-day moving average||$10.29|
|Wall St. target price||$12.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-2.12|
Buy Sensei Biotherapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Sensei Biotherapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Sensei Biotherapeutics price performance over time
|1 week (2021-10-20)||7.03%|
|1 month (2021-09-27)||-32.18%|
|3 months (2021-07-27)||3.76%|
|6 months (2021-04-27)||-44.04%|
|1 year (2020-10-23)||N/A|
|2 years (2019-10-23)||N/A|
|3 years (2018-10-23)||N/A|
|5 years (2016-10-23)||N/A|
Sensei Biotherapeutics financials
|Gross profit TTM||$0|
|Return on assets TTM||-103.29%|
|Return on equity TTM||0%|
|Market capitalisation||$215.6 million|
TTM: trailing 12 months
Shorting Sensei Biotherapeutics shares
There are currently 525,867 Sensei Biotherapeutics shares held short by investors – that's known as Sensei Biotherapeutics's "short interest". This figure is 121% up from 237,937 last month.
There are a few different ways that this level of interest in shorting Sensei Biotherapeutics shares can be evaluated.
Sensei Biotherapeutics's "short interest ratio" (SIR)
Sensei Biotherapeutics's "short interest ratio" (SIR) is the quantity of Sensei Biotherapeutics shares currently shorted divided by the average quantity of Sensei Biotherapeutics shares traded daily (recently around 181333.44827586). Sensei Biotherapeutics's SIR currently stands at 2.9. In other words for every 100,000 Sensei Biotherapeutics shares traded daily on the market, roughly 2900 shares are currently held short.
To gain some more context, you can compare Sensei Biotherapeutics's short interest ratio against those of similar companies.
However Sensei Biotherapeutics's short interest can also be evaluated against the total number of Sensei Biotherapeutics shares, or, against the total number of tradable Sensei Biotherapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Sensei Biotherapeutics's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Sensei Biotherapeutics shares in existence, roughly 20 shares are currently held short) or 0.025% of the tradable shares (for every 100,000 tradable Sensei Biotherapeutics shares, roughly 25 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Sensei Biotherapeutics.
Find out more about how you can short Sensei Biotherapeutics stock.
Sensei Biotherapeutics share dividends
We're not expecting Sensei Biotherapeutics to pay a dividend over the next 12 months.
Sensei Biotherapeutics overview
Sensei Biotherapeutics, Inc. , a clinical-stage immunotherapy company, engages in the discovery and development of therapies with an initial focus on treatments for cancer. The company develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune response. It is engineering ImmunoPhage product candidates to directly target antigen presenting cells and modulate the tumor microenvironment through the targeted use of nanobodies which further enhances therapeutic activity. Sensei Biotherapeutics, Inc. was formerly known as Panacea Pharmaceuticals, Inc. The company was founded in 1999 and is headquartered in Rockville, Maryland.
Sensei Biotherapeutics in the news
Sensei Biotherapeutics Inc Shares Close the Week 23.1% Lower - Weekly Wrap
Tracking Stanley Druckenmiller's Duquesne Family Office Portfolio - Q2 2021 Update
Sensei Biotherapeutics to Present New Preclinical Data for SNS-101, a Proprietary Anti-VISTA Antibody, at the 36th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
Frequently asked questionsWhat percentage of Sensei Biotherapeutics is owned by insiders or institutions?
Currently 36.64% of Sensei Biotherapeutics shares are held by insiders and 16.543% by institutions. How many people work for Sensei Biotherapeutics?
Latest data suggests 30 work at Sensei Biotherapeutics. When does the fiscal year end for Sensei Biotherapeutics?
Sensei Biotherapeutics's fiscal year ends in December. Where is Sensei Biotherapeutics based?
Sensei Biotherapeutics's address is: 1405 Research Boulevard, Rockville, MD, United States, 20850 What is Sensei Biotherapeutics's ISIN number?
Sensei Biotherapeutics's international securities identification number is: US81728A1088
More guides on Finder
How to buy ProShares Bitcoin Strategy ETF (BITO)
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
How to buy The Real Good Food Company (RGF) stock when it goes public
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
How to buy Lulu’s Fashion Lounge Holdings (LVLU) stock when it goes public
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
How to buy Allarity Therapeutics (ALLR) stock when it goes public
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
How to buy Jupiter Neurosciences (JUNS) stock when it goes public
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
How to buy Mainz Biomed (MYNZ) stock when it goes public
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
How to buy Progressive Care stock when it goes public
Everything we know about the Progressive Care IPO, plus information on how to buy in.
How to buy Desert Peak Minerals (DPM) stock when it goes public
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
How to buy Vaxxinity (VAXX) stock when it goes public
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
How to buy Entrada Therapeutics (TRDA) stock when it goes public
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
Ask an Expert